Rogelio A. Brito

Aetna (United States) — United States

Economics, Econometrics and Finance · Social Sciences

3h-index289citations29works0.12yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Economic and Financial Impacts of Cancer(8), Health Systems, Economic Evaluations, Quality of Life(6), Global Cancer Incidence and Screening(4), Cancer Genomics and Diagnostics(3), Cancer Treatment and Pharmacology(3)

Publications29 total

National Comprehensive Cancer Network guideline compliance in an oncology value-based care program serving Medicare members.

Journal of Clinical Oncology·2025

OCUPAÇÕES SEM PLANEJAMENTO E SEUS DANOS AOS CORPOS HÍDRICOS DO ENTORNO - ESTUDO DE CASO NO MUNICÍPIO DE PERUÍB

2025

OCUPAÇÕES SEM PLANEJAMENTO E SEUS DANOS AOS CORPOS HÍDRICOS DO ENTORNO - ESTUDO DE CASO NO MUNICÍPIO DE PERUÍBE

Journal of Engineering Research·2025Open Access

Fatores associados a sintomas depressivos e de ansiedade durante o puerpério na pandemia de covid-19

Ciência Cuidado e Saúde·2024Open Access

Administrative Aspects of Molecular Diagnostics—Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment Models

1 cited

JCO Oncology Practice·2024· 1 cited

Influence of health insurance type on time to breast cancer diagnosis and treatment among members of a large national payor.

Journal of Clinical Oncology·2024

National Comprehensive Cancer Network guideline compliance in an oncology value-based care program serving Medicare members.

Journal of Clinical Oncology·2024

Influence of sociodemographic factors on time to diagnosis and treatment among members of a large national payor diagnosed with lung cancer.

Journal of Clinical Oncology·2024

Differences in Radiotherapy-Treated Members with Cancer during COVID-19 Pandemic Using Nationwide Claim Data

International Journal of Radiation Oncology*Biology*Physics·2023Open Access

Using real-world evidence to evaluate broad panel vs. sequential single and narrow panel sequencing in members with non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology·2023

Impact of COVID-19 pandemic on breast cancer screening rates.

1 cited

Journal of Clinical Oncology·2023· 1 cited

Impact of early mammography screening on time to diagnosis.

Journal of Clinical Oncology·2023

Economic impact of broad panel versus sequential single and narrow panel sequencing in lung cancer patients.

Journal of Clinical Oncology·2022

The impact of an oncology-specific shared savings agreement.

1 cited

Journal of Clinical Oncology·2022· 1 cited

Site of service trend and chemotherapy costs of commercial insured patients in 2020 compared to 2014.

Journal of Clinical Oncology·2021

Impact of a regimen-level prior authorization tool on provider adherence to clinical guidelines’ and cost savings in a Medicare advantage population.

1 cited

Journal of Clinical Oncology·2021· 1 cited

Total cost of lung cancer care associated with broad panel versus narrow panel sequencing.

1 cited

Journal of Clinical Oncology·2020· 1 cited

Elevating the standard of care: Impact of a regimen-level prior authorization tool on provider adherence to clinical guidelines.

Journal of Clinical Oncology·2020

PB2133 IMPACT OF THE PRE‐TRANSPLANT INDUCTION (PTI) DURATION ON THE SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA (MM)

HemaSphere·2019Open Access

Dental approach of orofacial pain in head and neck cancer patients

2 cited

Journal of Clinical and Experimental Dentistry·2018· 2 citedOpen Access

page 1 of 2Next →

Frequent Co-authors

Elisea Avalos-Reyes(12), Kjel Andrew Johnson(10), Shirisha Reddy(8), Kevin Hastings(7), Brooke Byrd(7), Dorothea J. Verbrugge(5), Kelly Jean Thomas Craig(4), Heeseon Yeon(4), Robert Cullum(4), Richard Pazdur(3), Paulo M. Hoff(3), Diana C. Medgyesy(3), Melanie Royce(3), Alexa Hospodar(3), Cliff Rutter(3), Vicente Valero(2), Aman U. Buzdar(2), Daniel J. Booser(2), Frederick C. Ames(2), Eric A. Strom(2)